Analysis and Model Prediction of the Burden of Early-Onset Cancer Attributed to Overweight and Obesity in the Chinese Population From 1990 to 2021

Ting ZHANG, Fan LI, Yuping WANG

Acta Academiae Medicinae Sinicae ›› 2026, Vol. 48 ›› Issue (4) : 676-685.

PDF(1806 KB)
Home Journals Acta Academiae Medicinae Sinicae
Acta Academiae Medicinae Sinicae

Abbreviation (ISO4): Acta Academiae Medicinae Sinicae      Editor in chief: Xuetao CAO

About  /  Aim & scope  /  Editorial board  /  Indexed  /  Contact  / 
PDF(1806 KB)
Acta Academiae Medicinae Sinicae ›› 2026, Vol. 48 ›› Issue (4) : 676-685. DOI: 10.3881/j.issn.1000-503X.17015
Original Articles

Analysis and Model Prediction of the Burden of Early-Onset Cancer Attributed to Overweight and Obesity in the Chinese Population From 1990 to 2021

Author information +
History +

Abstract

Objective To analyze the trends in the burden of early-onset cancer attributed to overweight and obesity in China from 1990 to 2021 and to predicted its changes over the next 15 years,thus providing a reference for cancer prevention and control in China. Methods The data were sourced from the 2021 Global Burden of Disease database.The disease burden was described based on mortality rates,disability-adjusted life year (DALY) rates,and their age-standardized rates.R 4.4.1 software was used to analyze the differences and changes in disease burden across different gender and age groups.The Joinpoint regression model was adopted to quantify the temporal trends of the burden of early-onset cancer attributed to overweight and obesity in the Chinese population from 1990 to 2021,and the average annual percentage of change (AAPC) was calculated for age-standardized mortality rates and age-standardized DALY rates.An autoregressive integrated moving average model was established to predict changes in disease burden over the next 15 years. Results Between 1990 and 2021,the burden of early-onset cancers attributed to overweight and obesity in China showed an upward trend.The AAPC values of age-standardized mortality rates for men and women were 2.94% (95%CI=2.90-2.97) and 1.98% (95%CI=1.93-2.02),respectively,while those of age-standardized DALY rates were 2.88% (95%CI=2.83-2.91) and 1.82% (95%CI=1.77-1.86),respectively (all P<0.001).The age group of 30-34 years old in 2021 compared with 1990 saw the most significant increases (88.24% and 91.02%,respectively) in cancer mortality and DALY rates due to overweight and obesity.It was predicted that in the next 15 years,the age-standardized DALY rates for cancers (except female uterine cancer) attributed to overweight and obesity would keep rising.The top five cancers contributing to the disease burden in men would be colorectal cancer,liver cancer,leukemia,kidney cancer,and gallbladder and biliary tract cancer.For women,the top five cancers contributing to the disease burden in 2028 and earlier would be colon and rectum cancer,breast cancer,liver cancer,uterine cancer,and leukemia.From 2029 to 2036,ovarian cancer would surpass leukemia,rising to the fifth position. Conclusions From 1990 to 2021 and in the next 15 years,the burden of early-onset cancer attributed to overweight and obesity in China shows an overall upward trend.The main cancers causing the burden on men are colon and rectum cancer,liver cancer,leukemia,kidney cancer,and gallbladder and biliary tract cancer.The main cancers imposing the burden on women are colon and rectum cancer,breast cancer,liver cancer,uterine cancer,leukemia,and ovarian cancer.It is recommended that comprehensive prevention and control strategies should be improved for overweight and obesity and targeted interventions should be implemented for high-risk cancers and specific populations to reduce the burden of related cancer diseases.

Key words

cancer / overweight and obesity / disease burden / global burden of disease / prediction

Cite this article

Download Citations
Ting ZHANG , Fan LI , Yuping WANG. Analysis and Model Prediction of the Burden of Early-Onset Cancer Attributed to Overweight and Obesity in the Chinese Population From 1990 to 2021[J]. Acta Academiae Medicinae Sinicae. 2026, 48(4): 676-685 https://doi.org/10.3881/j.issn.1000-503X.17015

References

[1]
Akimoto N, Ugai T, Zhong R, et al. Rising incidence of early-onset colorectal cancer -a call to action[J]. Nat Rev Clin Oncol, 2021, 18(4):230-243.DOI:10.1038/s41571-020-00445-1.
[2]
Huang J, Ngai CH, Deng Y, et al. Cancer incidence and mortality in Asian countries:a trend analysis[J]. Cancer Control, 2022, 29:10732748221095955.DOI:10.1177/10732748221095955.
[3]
Di Martino E, Smith L, Bradley SH, et al. Incidence trends for twelve cancers in younger adults-a rapid review[J]. Br J Cancer, 2022, 126(10):1374-1386.DOI:10.1038/s41416-022-01704-x.
[4]
GBD 2021 Diseases and Injuries Collaborators. Global incidence,prevalence,years lived with disability (YLDs),disability-adjusted life-years (DALYs),and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations,1990-2021:a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet, 2024, 403(10440):2133-2161.DOI:10.1016/S0140-6736(24)00757-8.
[5]
van Dorp W, Haupt R, Anderson RA, et al. Reproductive function and outcomes in female survivors of childhood,adolescent,and young adult cancer:a review[J]. Clin Oncol, 2018, 36(21):2169-2180.DOI:10.1200/JCO.2017.76.3441.
[6]
Chao C, Xu L, Bhatia S, et al. Cardiovascular disease risk profiles in survivors of adolescent and young adult (AYA) cancer:the Kaiser Permanente AYA Cancer Survivors Study[J]. Clin Oncol, 2016, 34(14):1626-1633.DOI:10.1200/JCO.2015.65.5845.
[7]
Lee JS, Dubois SG, Coccia PF, et al. Increased risk of second malignant neoplasms in adolescents and young adults with cancer[J]. Cancer, 2016, 122(1):116-123.DOI:10.1002/cncr.29685.
[8]
NCD Risk Factor Collaboration. Worldwide trends in body-mass index,underweight,overweight,and obesity from 1975 to 2016:a pooled analysis of 2 416 population-based measurement studies in 128.9 million children,adolescents,and adults[J]. Lancet, 2017, 390(10113):2627-2642.DOI:10.1016/S0140-6736(17)32129-3.
[9]
Zhang H, Zhou XD, Shapiro MD, et al. Global burden of metabolic diseases,1990-2021[J]. Metabolism, 2024, 160:155999.DOI:10.1016/j.metabol.2024.155999.
[10]
Hendren NS, de Lemos JA, Ayers C, et al. Association of body mass index and age with morbidity and mortality in patients hospitalized with COVID-19:results from the American Heart Association COVID-19 Cardiovascular Disease Registry[J]. Circulation, 2021, 143(2):135-144.DOI:10.1161/CIRCULATIONAHA.120.051936.
[11]
Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer:a systematic review and meta-analysis of prospective observational studies[J]. Lancet, 2008, 371(9612):569-578.DOI:10.1016/S0140-6736(08)60269-X.
[12]
Basen-Engquist K, Chang M. Obesity and cancer risk:recent review and evidence[J]. Curr Oncol Rep, 2011, 13(1):71-76.DOI:10.1007/s11912-010-0139-7.
[13]
GBD 2021 Adult BMI Collaborators. Global,regional,and national prevalence of adult overweight and obesity,1990-2021,with forecasts to 2050:a forecasting study for the Global Burden of Disease Study 2021[J]. Lancet, 2025,405(10481):813-838.DOI:10.1016/S0140-6736(25)00355-1.
[14]
GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations,1990-2021:a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet, 2024,403(10440):2162-2203.DOI:10.1016/S0140-6736(24)00933-4.
[15]
GBD 2021 Child and Adolescent BMI Collaborators. Global,regional,and national prevalence of child and adolescent overweight and obesity,1990-2021,with forecasts to 2050:a forecasting study for the Global Burden of Disease Study 2021[J]. Lancet, 2025,405(10481):785-812.DOI:10.1016/S0140-6736(25)00397-6.
[16]
Sung H, Siegel RL, Rosenberg PS, et al. Emerging cancer trends among young adults in the USA:analysis of a population-based cancer registry[J]. Lancet Public Health, 2019, 4(3):e137-e147.DOI:10.1016/S2468- 2667(18)30267-6.
[17]
Figlioli G, Piovani D, Tsantes AG, et al. Burden of cancer attributable to high body mass index:a systematic analysis of the Global Burden of Disease Study 2021[J]. Clin Nutr, 2025, 48:144-152.DOI:10.1016/j.clnu.2025.04.002.
[18]
Zhu J, Li T, Chen J, et al. Trends in the disease burden of early-onset cancers in China from 1990 to 2021:a systematic analysis of the 2021 Global Burden of Disease Study[J]. BMC Cancer, 2025, 25(1):1168.DOI:10.1186/s12885-025-14578-y.
[19]
Lega IC, Lipscombe LL. Review:diabetes,obesity,and cancer-pathophysiology and clinical implications[J]. Endocr Rev, 2019, 41(1):33-52.DOI:10.1210/endrev/bnz014.
[20]
Jones AN, Scheurlen KM, Macleod A, et al. Obesity and inflammatory factors in the progression of early-onset colorectal cancer[J]. Cancers, 2024, 16(7):1403.DOI:10.3390/cancers16071403.
[21]
Vermorken AJM, Zhu J, Andrès E. Obesity and colorectal cancer risk:the role of oxidative stress[J]. Gut, 2014, 63(3):529-530.DOI:10.1136/gutjnl-2013-305561.
[22]
Leanza G, Conte C, Cannata F, et al. Oxidative stress in postmenopausal women with or without obesity[J]. Cells, 2023, 12(8):1137.DOI:10.3390/cells12081137.
[23]
Kant P, Hull MA. Excess body weight and obesity-the link with gastrointestinal and hepatobiliary cancer[J]. Nat Rev Gastroenterol Hepatol, 2011, 8(4):224-238.DOI:10.1038/nrgastro.2011.23.
[24]
Ahechu P, Zozaya G, Martí P, et al. NLRP3 inflammasome:a possible link between obesity-associated low-grade chronic inflammation and colorectal cancer development[J]. Front Immunol, 2018, 9:2918.DOI:10.3389/fimmu.2018.02918.
[25]
Moon SG, Park B. The association between metabolic syndrome and colorectal cancer risk by obesity status in Korean women:a nationwide cohort study[J]. J Prev Med Public Health, 2022, 55(5):475-484.DOI:10.3961/jpmph.22.286.
[26]
Berryman DE, Glad CA, List EO, et al. The GH/IGF-1 axis in obesity:pathophysiology and therapeutic considerations[J]. Nat Rev Endocrinol, 2013, 9(6):346-356.DOI:10.1038/nrendo.2013.64.
[27]
Dai H, Alsalhe TA, Chalghaf N, et al. The global burden of disease attributable to high body mass index in 195 countries and territories,1990-2017:an analysis of the Global Burden of Disease Study[J]. PLoS Med, 2020, 17(7):e1003198.DOI:10.1371/journal.pmed.1003198.
[28]
Sung H, Siegel RL, Torre LA, et al. Global patterns in excess body weight and the associated cancer burden[J]. CA Cancer J Clin, 2019, 69(2):88-112.DOI:10.3322/caac.21499.
[29]
Berger NA. Young adult cancer:influence of the obesity pandemic[J]. Obesity (Silver Spring), 2018, 26(4):641-650. DOI:10.1002/oby.22137.
[30]
Eliassen AH, Colditz GA, Rosner B, et al. Adult weight change and risk of postmenopausal breast cancer[J]. JAMA, 2006, 296(2):193-201.DOI:10.1001/jama.296.2.193.
[31]
Shaw E, Farris M, McNeil J, et al. Obesity and endometrial cancer[J]. Recent Results Cancer Res, 2016, 208:107-136. DOI:10.1007/978-3-319-42542-9_7.

Footnotes

利益冲突 所有作者声明无利益冲突

PDF(1806 KB)

Accesses

Citation

Detail

Sections
Recommended

/